Skip to content

Clinical trials

Phase 2 Endometrial Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Phase: Phase 2 Country / region: Australia Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20121
20161
20221
20232
20243
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6
Completed4
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gynecologic Oncology Group2
Bayer1
Canadian Cancer Trials Group1
Daiichi Sankyo1
Merck Sharp & Dohme LLC1
Millennium Pharmaceuticals, Inc.1
Pfizer1
Psyence Australia Pty Ltd1
Queensland Centre for Gynaecological Cancer1
Seagen, a wholly owned subsidiary of Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms12
Ovarian Neoplasms4
Breast Neoplasms3
Pancreatic Neoplasms3
Stomach Neoplasms3
Uterine Cervical Neoplasms3
Carcinoma, Non-Small-Cell Lung2
Esophageal Neoplasms2
Head and Neck Neoplasms2
Melanoma2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.